Malaria Consortium is pleased to be part of a major project led by Abt Associates that has been awarded by the United States Agency for International Development (USAID) through the U.S. President’s Malaria Initiative (PMI) under the Prevention of Mosquito-Borne Diseases through Vector Control.
The contract will involve supporting planning and implementation of indoor residual spraying (IRS) programmes and other proven, life-saving malaria vector control interventions with the overall goal of reducing the burden of malaria in Africa.
Malaria Consortium’s expected role will be to support National Malaria Control Programmes (NMCPs) and local institutions in several African countries with technical assistance: to build their capacity to collect, analyse and use entomological, epidemiological and vector control activity coverage data for strategic malaria vector control decision-making and to develop effective national integrated malaria vector control strategies; and in conjunction with other partners on the team, pilot and conduct operations research on promising new vector control tools and technologies.
“We will support NMCPs in taking strategic decisions on appropriate, cost-effective combinations of interventions for vector control, including IRS, insecticide-treated nets (ITNs) and other vector control activities,” said Dr James Tibenderana, Malaria Consortium’s Technical Director.
Charles Nelson, Malaria Consortium’s Chief Executive, added, “Since our inception, we have partnered with all levels of government in the countries that we serve. It is one of our core areas of expertise to build linkages between them and the research and private sectors. These linkages ensure programmes are sustainable as they establish government ownership.”
Other partners in the delivery of this contract are Population Services International, PATH, Liverpool School of Tropical Medicine, Innovative Vector Control Consortium and McKinsey & Company, Inc., as well as three small businesses, EnCompass LLC, BAO Systems LLC, and Dimagi, Inc.